S1P1 agonist III - HY-12835
Nur noch %1 verfügbar
Catalog #
HY-12835
Ab
83,00 €
S1P1 Agonist III is a potent and orally active S1P1 agonist with EC50 of 18 nM; no activity on S1P3.
IC50 value: 18 nM(EC50) [1]
Target: S1P1 agonist
When dosed orally at 1 and 3 mg/kg, the azahydroxymethyl analogue 22(HY-12835) achieved statistically significant lowering of circulating blood lymphocytes 24 h postdose. In rats, a dose-proportional increase in exposure was measured when 22(HY-12835) was dosed orally at 2 and 100 mg/kg. 22 displayed excellent pharmacokinetic parameters with low clearance (CL = 0.11 L/h/kg), long mean residence time (40 h), and good oral bioavailability (F = 67%).
IC50 value: 18 nM(EC50) [1]
Target: S1P1 agonist
When dosed orally at 1 and 3 mg/kg, the azahydroxymethyl analogue 22(HY-12835) achieved statistically significant lowering of circulating blood lymphocytes 24 h postdose. In rats, a dose-proportional increase in exposure was measured when 22(HY-12835) was dosed orally at 2 and 100 mg/kg. 22 displayed excellent pharmacokinetic parameters with low clearance (CL = 0.11 L/h/kg), long mean residence time (40 h), and good oral bioavailability (F = 67%).
Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-12835/S1P1-agonist-III-DataSheet-MedChemExpress.pdf |
---|---|
Shipping | Room Temperature |
Application | Neuroscience-Neuromodulation |
CAS | 1324003-64-6 |
Storage | -20°C, 3 years; 4°C, 2 years (Powder) |
MWT | 415.37 |
Solubility | DMSO : 62.5 mg/mL (ultrasonic) |
Clinical Information | No Development Reported |
Target | LPL Receptor |
Application: | Neuroscience-Neuromodulation |
---|